MENU
+Compare
TBPH
Stock ticker: NASDAQ
AS OF
Sep 16, 03:01 PM (EDT)
Price
$13.97
Change
-$0.43 (-2.99%)
Capitalization
725.2M

TBPH Theravance Biopharma Forecast, Technical & Fundamental Analysis

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines... Show more

TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TBPH with price predictions
Sep 15, 2025

Momentum Indicator for TBPH turns positive, indicating new upward trend

TBPH saw its Momentum Indicator move above the 0 level on September 12, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned positive. In of the 100 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where TBPH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TBPH advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 144 cases where TBPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for TBPH turned negative on September 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 61 similar instances when the indicator turned negative. In of the 61 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TBPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TBPH broke above its upper Bollinger Band on September 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TBPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.226) is normal, around the industry mean (20.594). P/E Ratio (60.000) is within average values for comparable stocks, (53.282). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.156). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (9.311) is also within normal values, averaging (342.112).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TBPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TBPH is expected to report earnings to fall 112.36% to -13 cents per share on November 05

Theravance Biopharma TBPH Stock Earnings Reports
Q3'25
Est.
$-0.13
Q2'25
Beat
by $0.41
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.11
Q3'24
Missed
by $0.03
The last earnings report on August 12 showed earnings per share of $1.08, beating the estimate of 67 cents. With 84.02K shares outstanding, the current market capitalization sits at 725.20M.
A.I. Advisor
published General Information

General Information

a developer of small molecule pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRDFX12.99N/A
N/A
Steward Values Enhanced SmMidCapA
BRXIX16.75N/A
N/A
MFS Blended Research Intl Eq I
JGRUX89.64N/A
N/A
JPMorgan US Value R4
RAZCX11.57N/A
N/A
Russell Inv Multi-Asset Strat C
MKECX12.80N/A
N/A
BlackRock Emerging Markets Ex-China K

TBPH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
+0.70%
KYMR - TBPH
49%
Loosely correlated
+0.62%
VERA - TBPH
37%
Loosely correlated
+1.98%
IMCR - TBPH
35%
Loosely correlated
-2.33%
RGNX - TBPH
35%
Loosely correlated
-1.20%
LYRA - TBPH
35%
Loosely correlated
-0.16%
More